Humane Genomics

Humane Genomics is developing oncolytic viruses with a modular synthetic biology platform to create targeted cancer therapies for oncologists and patients. Their key differentiation lies in overcoming the traditional tradeoff between therapeutic potency and selectivity in oncolytic viruses by employing a novel two-fact

Humane Genomics is a business in cancer based in New York City, NY, USA; New York, NY, USA, founded in 2019.

Profile

Humane Genomics is developing oncolytic viruses with a modular synthetic biology platform to create targeted cancer therapies for oncologists and patients. Their key differentiation lies in overcoming the traditional tradeoff between therapeutic potency and selectivity in oncolytic viruses by employing a novel two-factor authentication mechanism for selectivity (cancer-specific receptors for honing, cancer-specific proteins for activation). […]

The company sits in the cancer segment, where it competes on its core product or service.

Its base of operations is New York City, NY, USA; New York, NY, USA.

It is recorded at the Summer 2021 stage.

Its team size is recorded as 5 employees.

Website: humanegenomics.com